Privia Health Group, Inc. (PRVA) stock: analyst price target and their real reliability
Live quote · data updated Aug 28, 2026
Privia Health Group, Inc. · Health Care · ref. ETF XLV · 56 calls · price $20.86
What the company does: Privia Health Group, Inc. operates as a national physician-enablement company in the United States.
📈 Privia Health Group, Inc. (PRVA) stock price
$20.86-4.4% over range
Aug 28, 25low $20.02 · high $28.1Aug 27, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
80% recommend buying · 5 analysts
📊 JPI status : Privia Health Group, Inc. is no longer in our current JPI rankings, but appeared in the past (2024) — its upside may be behind it. See the stocks picked in 2024 →
🎯 PRVA price target & analyst consensus — price $20.86
The price target · all analysts combined (5 targets)
Highest target · 1 firm of 5$34+63.0%
Median target · of 5 targets$32+53.4%
Lowest target · 1 firm of 5$24+15.1%
Current price$20.86
Where these 5 targets sit · versus the current price · 1 target per firm, last 6 months
Above the price
5100%
$24 ↔ $34
⭐ What the most reliable analysts say
No reliable analyst is bullish on this stock right now. A “reliable” analyst is a firm that, on this sector, hits more than 55% of its targets and beats its sector. None of them sees upside here — which is exactly why this stock is in no JPI selection.
The consensus · 5 ratings (last 6 months)
Strong Buy00%
Buy480%
Hold120%
Sell00%
Strong Sell00%
Go deeper on the analysts
🎯 PRVA price target all
All 56 calls, one by one, with our verdict on each firm.
→ See all 56 targets, analyst by analyst💡 The best analysts on PRVA most reliable
The case for and against, with the numbers, per those who've been right on the stock.
→ Should you invest in PRVA? The case for & againstAll analysts (the consensus) · vs · the best (those who've been right)
💬 A question about Privia Health Group, Inc.? The JPI assistant answers using our backtest data.
🔎 Detailed analyses
✅ Historical analyst reliability on PRVA
Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.
| Firm ↕ | % right i ↕ | Gain vs sector i ↕ | Calls i ↕ |
|---|---|---|---|
| Evercore ISI Group ↗ | 75% | +6.7% | 4 |
| Baird ↗ | 67% | +9.8% | 3 |
| Stephens & Co. ↗ | 67% | +2.3% | 3 |
| JMP Securities | 67% | -1.4% | 3 |
| Stifel ↗ | 50% | +9.6% | 2 |
| Canaccord Genuity ↗ | 50% | -1.4% | 8 |
| RBC Capital ↗ | 50% | -2.0% | 2 |
| Cowen & Co. | 50% | -7.6% | 2 |
| TD Cowen ↗ | 50% | -8.5% | 2 |
| Guggenheim ↗ | 50% | -12.8% | 2 |
See the other 7 firms
| Credit Suisse | 14% | -24.6% | 7 |
| Piper Sandler ↗ | 33% | -8.1% | 3 |
| UBS ↗ | 33% | -4.7% | 3 |
| JP Morgan ↗ | 40% | -3.7% | 5 |
| Needham ↗ | 40% | +1.6% | 5 |
| Truist Securities ↗ | 43% | -3.1% | 7 |
| SVB Leerink | 43% | -1.1% | 7 |
📊 What $1,000 invested in Privia Health Group, Inc. would be worth › open the full page
In short — $1,000 invested in Privia Health Group, Inc. 10 years ago would be worth $772 today, i.e. -5%/yr on average. Best year: 2025 (+18%), worst: 2024 (-13%). Price performance, excluding dividends.
If I'd invested $1,000 in Privia Health Group, Inc.
| Investment | Worth today | Gain |
|---|---|---|
| 1 years ago | $1,404 | +40% |
| 3 years ago | $1,234 | +23% |
| 5 years ago | $772 | -23% |
Return by year (Privia Health Group, Inc.)
| Year | Return | $1,000 invested at year start |
|---|---|---|
| 2026 (YTD) | +19% | $1,195 (+19%) |
| 2025 | +18% | $1,404 (+40%) |
| 2024 | -13% | $1,217 (+22%) |
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.
📰 Recent news on Privia Health Group, Inc.
Loading news…
📋 All analyst calls on PRVA
Filtered on — · ✕ show all
■ Equal-Weight neutral · not a buy · 🎯$24
Price at call : $21.74 — gap to target +10%
Today : $20.86 — gap to target +15%
🎯 on PRVA : no call matured yet · 📊 on Health : 37.3% · -8.4% (150 calls)
in progress (365j)
matures : May 26, 27
matures : May 26, 27
Canaccord Genuity ↗
May 9, 26
▲ Buy · 🎯$34
Price at call : $22.76 — upside +49%
Today : $20.86 — upside +63%
🎯 on PRVA : 50% (8 calls matureds) · 📊 on Health : 38.9% · -0.9% (144 calls)
in progress (365j)
matures : May 9, 27
matures : May 9, 27
Evercore ISI Group ↗
Apr 8, 26
▲ Outperform · 🎯$26
Price at call : $22.71 — upside +14%
Today : $20.86 — upside +25%
🎯 on PRVA : 100% (2 calls matureds) · 📊 on Health : 37.9% · -7.6% (29 calls)
in progress (365j)
matures : Apr 8, 27
matures : Apr 8, 27
■ Equal-Weight neutral · not a buy · 🎯$25
Price at call : $20.54 — gap to target +22%
Today : $20.86 — gap to target +20%
🎯 on PRVA : no call matured yet · 📊 on Health : 37.3% · -8.4% (150 calls)
in progress (365j)
matures : Mar 25, 27
matures : Mar 25, 27
▲ Buy · 🎯$32
Price at call : $24.3 — upside +32%
Today : $20.86 — upside +53%
🎯 on PRVA : no call matured yet · 📊 on Health : 43.8% · -5.4% (105 calls)
in progress (365j)
matures : Mar 3, 27
matures : Mar 3, 27
Truist Securities ↗
Mar 2, 26
▲ Buy · 🎯$33
Price at call : $24.04 — upside +37%
Today : $20.86 — upside +58%
🎯 on PRVA : 67% (3 calls matureds) · 📊 on Health : 37.6% · -0.8% (165 calls)
in progress (365j)
matures : Mar 2, 27
matures : Mar 2, 27
Canaccord Genuity ↗
Feb 27, 26
▲ Buy · 🎯$35
Price at call : $24.04 — upside +46%
Today : $20.86 — upside +68%
🎯 on PRVA : 50% (8 calls matureds) · 📊 on Health : 38.9% · -0.9% (144 calls)
in progress (365j)
matures : Feb 27, 27
matures : Feb 27, 27
Stephens & Co. ↗
Dec 4, 25
▲ Overweight · 🎯$32
Price at call : $24 — upside +33%
Today : $20.86 — upside +53%
🎯 on PRVA : 100% (2 calls matureds) · 📊 on Health : 46.4% · +3.2% (84 calls)
in progress (365j)
matures : Dec 4, 26
matures : Dec 4, 26
See the other 48 calls, newest to oldest
▲ Overweight · 🎯$33
Price at call : $23.45 — upside +41%
Today : $20.86 — upside +58%
🎯 on PRVA : 50% (2 calls matureds) · 📊 on Health : 49.3% · +6.9% (146 calls)
in progress (365j)
matures : Nov 13, 26
matures : Nov 13, 26
BMO Capital ↗
Nov 13, 25
▲ Outperform · 🎯$30
Price at call : $23.75 — upside +26%
Today : $20.86 — upside +44%
🎯 on PRVA : no call matured yet · 📊 on Health : 43.9% · -2.1% (66 calls)
in progress (365j)
matures : Nov 13, 26
matures : Nov 13, 26
Canaccord Genuity ↗
Nov 12, 25
▲ Buy · 🎯$34
Price at call : $24.22 — upside +40%
Today : $20.86 — upside +63%
🎯 on PRVA : 50% (8 calls matureds) · 📊 on Health : 38.9% · -0.9% (144 calls)
in progress (365j)
matures : Nov 12, 26
matures : Nov 12, 26
■ Equal-Weight neutral · not a buy · 🎯$23
Price at call : $24.32 — gap to target -5%
Today : $20.86 — gap to target +10%
🎯 on PRVA : no call matured yet · 📊 on Health : 37.3% · -8.4% (150 calls)
in progress (365j)
matures : Nov 10, 26
matures : Nov 10, 26
Truist Securities ↗
Nov 10, 25
▲ Buy · 🎯$31
Price at call : $24.32 — upside +27%
Today : $20.86 — upside +49%
🎯 on PRVA : 67% (3 calls matureds) · 📊 on Health : 37.6% · -0.8% (165 calls)
in progress (365j)
matures : Nov 10, 26
matures : Nov 10, 26
Evercore ISI Group ↗
Nov 7, 25
▲ Outperform · 🎯$30
Price at call : $23.41 — upside +28%
Today : $20.86 — upside +44%
🎯 on PRVA : 100% (2 calls matureds) · 📊 on Health : 37.9% · -7.6% (29 calls)
in progress (365j)
matures : Nov 7, 26
matures : Nov 7, 26
Citizens
Nov 7, 25
▲ Market Outperform · 🎯$31
Price at call : $23.43 — upside +32%
Today : $20.86 — upside +49%
🎯 on PRVA : no call matured yet · 📊 unranked overall
in progress (365j)
matures : Nov 7, 26
matures : Nov 7, 26
■ Equal-Weight neutral · not a buy · 🎯$22
Price at call : $24.2 — gap to target -9%
Today : $20.86 — gap to target +5%
🎯 on PRVA : no call matured yet · 📊 on Health : 37.3% · -8.4% (150 calls)
in progress (365j)
matures : Oct 9, 26
matures : Oct 9, 26
Stephens & Co. ↗
Sep 24, 25
▲ Overweight · 🎯$32
Price at call : $23.34 — upside +37%
Today : $20.86 — upside +53%
🎯 on PRVA : 100% (2 calls matureds) · 📊 on Health : 46.4% · +3.2% (84 calls)
in progress (365j)
matures : Sep 24, 26
matures : Sep 24, 26
Stephens & Co. ↗
Sep 4, 25
▲ Overweight · 🎯$32
Price at call : $23.12 — upside +38%
Today : $20.86 — upside +53%
🎯 on PRVA : 100% (2 calls matureds) · 📊 on Health : 46.4% · +3.2% (84 calls)
in progress (365j)
matures : Sep 4, 26
matures : Sep 4, 26
JMP Securities
Aug 29, 25
▲ Market Outperform · 🎯$30
Price at call : $23.19 — upside +29%
Today : $20.86 — upside +44%
🎯 on PRVA : 50% (2 calls matureds) · 📊 unranked overall
in progress (365j)
matures : Aug 29, 26
matures : Aug 29, 26
Piper Sandler ↗
Aug 11, 25
▲ Overweight · 🎯$35
Price at call : $20.31 — upside +72%
Today : $20.86 — upside +68%
Expected +72% · Actual +8% · Reason (≥ +15%) : ✗ No
🎯 on PRVA : 50% (2 calls matureds) · 📊 on Health : 45.8% · +6.9% (249 calls)
+8.2%
stock +8% · XLV +29%
matured Aug 11, 26
Evercore ISI Group ↗
Jul 9, 25
▲ Outperform · 🎯$28
Price at call : $21.2 — upside +32%
Today : $20.86 — upside +34%
Expected +32% · Actual +31% · Reason (≥ +15%) : ✓ Yes
🎯 on PRVA : 100% (2 calls matureds) · 📊 on Health : 37.9% · -7.6% (29 calls)
+31.0%
stock +31% · XLV +20%
matured Jul 9, 26
▲ Overweight · 🎯$32
Price at call : $22.55 — upside +42%
Today : $20.86 — upside +53%
Expected +42% · Actual -5% · Reason (≥ +15%) : ✗ No
🎯 on PRVA : 50% (2 calls matureds) · 📊 on Health : 49.3% · +6.9% (146 calls)
-4.6%
stock -5% · XLV +13%
matured May 28, 26
■ Equal-Weight neutral · not a buy · 🎯$24
Price at call : $23.07 — gap to target +4%
Today : $20.86 — gap to target +15%
🎯 on PRVA : no call matured yet · 📊 on Health : 37.3% · -8.4% (150 calls)
in progress (365j)
matures : May 27, 26
matures : May 27, 26
JMP Securities
Apr 28, 25
▲ Market Outperform · 🎯$29
Price at call : $23.41 — upside +24%
Today : $20.86 — upside +39%
Expected +24% · Actual +5% · Reason (≥ +15%) : ✗ No
🎯 on PRVA : 50% (2 calls matureds) · 📊 unranked overall
+5.5%
stock +5% · XLV +3%
matured Apr 28, 26
▲ Outperform · 🎯$26
Price at call : $24.19 — upside +7%
Today : $20.86 — upside +25%
Expected +7% · Actual -3% · Reason (≥ +15%) : ✗ No
🎯 on PRVA : 67% (3 calls matureds) · 📊 on Health : 37.8% · -2.8% (82 calls)
-3.1%
stock -3% · XLV +7%
matured Apr 15, 26
■ Equal-Weight neutral · not a buy · 🎯$23
Price at call : $24.1 — gap to target -5%
Today : $20.86 — gap to target +10%
🎯 on PRVA : no call matured yet · 📊 on Health : 37.3% · -8.4% (150 calls)
in progress (365j)
matures : Apr 10, 26
matures : Apr 10, 26
Truist Securities ↗
Apr 10, 25
▲ Buy · 🎯$28
Price at call : $23.65 — upside +18%
Today : $20.86 — upside +34%
Expected +18% · Actual -5% · Reason (≥ +15%) : ✗ No
🎯 on PRVA : 67% (3 calls matureds) · 📊 on Health : 37.6% · -0.8% (165 calls)
-5.4%
stock -5% · XLV +9%
matured Apr 10, 26
▲ Buy · 🎯$30
Price at call : $23.65 — upside +27%
Today : $20.86 — upside +44%
Expected +27% · Actual -5% · Reason (≥ +15%) : ✗ No
🎯 on PRVA : 40% (5 calls matureds) · 📊 on Health : 39% · -2.9% (397 calls)
-5.4%
stock -5% · XLV +9%
matured Apr 10, 26
▲ Buy · 🎯$30
Price at call : $23.34 — upside +29%
Today : $20.86 — upside +44%
Expected +29% · Actual -8% · Reason (≥ +15%) : ✗ No
🎯 on PRVA : 40% (5 calls matureds) · 📊 on Health : 39% · -2.9% (397 calls)
-7.8%
stock -8% · XLV -1%
matured Mar 21, 26
Citizens Capital Markets
Feb 28, 25
▲ Market Outperform · 🎯$29
Price at call : $24.96 — upside +16%
Today : $20.86 — upside +39%
Expected +16% · Actual -4% · Reason (≥ +15%) : ✗ No
🎯 on PRVA : 0% (1 call matured) · 📊 unranked overall
-3.7%
stock -4% · XLV +6%
matured Feb 28, 26
Canaccord Genuity ↗
Feb 28, 25
▲ Buy · 🎯$30
Price at call : $24.96 — upside +20%
Today : $20.86 — upside +44%
Expected +20% · Actual -4% · Reason (≥ +15%) : ✗ No
🎯 on PRVA : 50% (8 calls matureds) · 📊 on Health : 38.9% · -0.9% (144 calls)
-3.7%
stock -4% · XLV +6%
matured Feb 28, 26
Piper Sandler ↗
Feb 28, 25
▲ Overweight · 🎯$40
Price at call : $24.97 — upside +60%
Today : $20.86 — upside +92%
Expected +60% · Actual -4% · Reason (≥ +15%) : ✗ No
🎯 on PRVA : 50% (2 calls matureds) · 📊 on Health : 45.8% · +6.9% (249 calls)
-3.7%
stock -4% · XLV +6%
matured Feb 28, 26
▲ Buy · 🎯$30
Price at call : $24.97 — upside +20%
Today : $20.86 — upside +44%
Expected +20% · Actual -4% · Reason (≥ +15%) : ✗ No
🎯 on PRVA : 40% (5 calls matureds) · 📊 on Health : 39% · -2.9% (397 calls)
-3.7%
stock -4% · XLV +6%
matured Feb 28, 26
JMP Securities
Feb 14, 25
▲ Market Outperform · 🎯$26
Price at call : $25.04 — upside +4%
Today : $20.86 — upside +25%
Expected +4% · Actual -12% · Reason (≥ +15%) : ✗ No
🎯 on PRVA : 50% (2 calls matureds) · 📊 unranked overall
-11.8%
stock -12% · XLV +9%
matured Feb 14, 26
▲ Buy · 🎯$25
Price at call : $21.57 — upside +16%
Today : $20.86 — upside +20%
Expected +16% · Actual +11% · Reason (≥ +15%) : ✗ No
🎯 on PRVA : 40% (5 calls matureds) · 📊 on Health : 39% · -2.9% (397 calls)
+10.6%
stock +11% · XLV +12%
matured Jan 15, 26
▲ Buy · 🎯$25
Price at call : $20.51 — upside +22%
Today : $20.86 — upside +20%
Expected +22% · Actual +14% · Reason (≥ +15%) : ✗ No
🎯 on PRVA : 40% (5 calls matureds) · 📊 on Health : 39% · -2.9% (397 calls)
+14.2%
stock +14% · XLV +13%
matured Jan 10, 26
Stephens & Co. ↗
Jan 7, 25
▲ Overweight · 🎯$26
Price at call : $20.3 — upside +28%
Today : $20.86 — upside +25%
Expected +28% · Actual +19% · Reason (≥ +15%) : ✓ Yes
🎯 on PRVA : 100% (2 calls matureds) · 📊 on Health : 46.4% · +3.2% (84 calls)
+19.2%
stock +19% · XLV +14%
matured Jan 7, 26
Stephens & Co. ↗
Jan 2, 25
▲ Overweight · 🎯$26
Price at call : $19.64 — upside +32%
Today : $20.86 — upside +25%
Expected +32% · Actual +19% · Reason (≥ +15%) : ✓ Yes
🎯 on PRVA : 100% (2 calls matureds) · 📊 on Health : 46.4% · +3.2% (84 calls)
+19.4%
stock +19% · XLV +13%
matured Jan 2, 26
▲ Outperform · 🎯$25
Price at call : $21.87 — upside +14%
Today : $20.86 — upside +20%
Expected +14% · Actual +9% · Reason (≥ +15%) : ✗ No
🎯 on PRVA : 100% (1 call matured) · 📊 on Health : 40% · +4.7% (10 calls)
+8.9%
stock +9% · XLV +11%
matured Dec 16, 25
▲ Overweight · 🎯$28
Price at call : $22.31 — upside +26%
Today : $20.86 — upside +34%
Expected +26% · Actual +8% · Reason (≥ +15%) : ✗ No
🎯 on PRVA : 50% (2 calls matureds) · 📊 on Health : 49.3% · +6.9% (146 calls)
+8.0%
stock +8% · XLV +6%
matured Nov 29, 25
■ Equal-Weight neutral · not a buy · 🎯$21
Price at call : $22.8 — gap to target -8%
Today : $20.86 — gap to target +1%
🎯 on PRVA : no call matured yet · 📊 on Health : 37.3% · -8.4% (150 calls)
in progress (365j)
matures : Nov 8, 25
matures : Nov 8, 25
Truist Securities ↗
Nov 8, 24
▲ Buy · 🎯$27
Price at call : $22.8 — upside +18%
Today : $20.86 — upside +29%
Expected +18% · Actual +3% · Reason (≥ +15%) : ✗ No
🎯 on PRVA : 67% (3 calls matureds) · 📊 on Health : 37.6% · -0.8% (165 calls)
+2.7%
stock +3% · XLV -1%
matured Nov 8, 25
▲ Overweight · 🎯$23
Price at call : $17.76 — upside +30%
Today : $20.86 — upside +10%
Expected +30% · Actual +36% · Reason (≥ +15%) : ✓ Yes
🎯 on PRVA : 100% (1 call matured) · 📊 on Health : 25.2% · -18.3% (107 calls)
+35.9%
stock +36% · XLV -8%
matured Oct 11, 25
▲ Outperform · 🎯$24
Price at call : $21.29 — upside +13%
Today : $20.86 — upside +15%
Expected +13% · Actual +0% · Reason (≥ +15%) : ✗ No
🎯 on PRVA : 67% (3 calls matureds) · 📊 on Health : 37.8% · -2.8% (82 calls)
+0.5%
stock +0% · XLV -12%
matured Aug 26, 25
RBC Capital ↗
Aug 14, 24
▲ Outperform · 🎯$28
Price at call : $19.53 — upside +43%
Today : $20.86 — upside +34%
Expected +43% · Actual +9% · Reason (≥ +15%) : ✗ No
🎯 on PRVA : 100% (1 call matured) · 📊 on Health : 30.7% · -10.7% (166 calls)
+8.9%
stock +9% · XLV -11%
matured Aug 14, 25
Evercore ISI Group ↗
Jul 9, 24
▲ Outperform · 🎯$20
Price at call : $17.11 — upside +17%
Today : $20.86 — upside -4%
Expected +17% · Actual +23% · Reason (≥ +15%) : ✓ Yes
🎯 on PRVA : 100% (2 calls matureds) · 📊 on Health : 37.9% · -7.6% (29 calls)
+23.3%
stock +23% · XLV -7%
matured Jul 9, 25
▲ Outperform · 🎯$23
Price at call : $17.26 — upside +33%
Today : $20.86 — upside +10%
Expected +33% · Actual +32% · Reason (≥ +15%) : ✓ Yes
🎯 on PRVA : 67% (3 calls matureds) · 📊 on Health : 37.8% · -2.8% (82 calls)
+31.9%
stock +32% · XLV -6%
matured May 30, 25
■ Equal-Weight neutral · not a buy · 🎯$19
Price at call : $16.15 — gap to target +18%
Today : $20.86 — gap to target -9%
🎯 on PRVA : no call matured yet · 📊 on Health : 37.3% · -8.4% (150 calls)
in progress (365j)
matures : May 20, 25
matures : May 20, 25
Truist Securities ↗
May 15, 24
▲ Buy · 🎯$24
Price at call : $17 — upside +41%
Today : $20.86 — upside +15%
Expected +41% · Actual +47% · Reason (≥ +15%) : ✓ Yes
🎯 on PRVA : 67% (3 calls matureds) · 📊 on Health : 37.6% · -0.8% (165 calls)
+47.2%
stock +47% · XLV -9%
matured May 15, 25
Canaccord Genuity ↗
May 10, 24
▲ Buy · 🎯$26
Price at call : $17.99 — upside +45%
Today : $20.86 — upside +25%
Expected +45% · Actual +39% · Reason (≥ +15%) : ✓ Yes
🎯 on PRVA : 50% (8 calls matureds) · 📊 on Health : 38.9% · -0.9% (144 calls)
+39.3%
stock +39% · XLV -5%
matured May 10, 25
Canaccord Genuity ↗
Mar 19, 24
▲ Buy · 🎯$37
Price at call : $20.88 — upside +77%
Today : $20.86 — upside +77%
Expected +77% · Actual +13% · Reason (≥ +15%) : ✗ No
🎯 on PRVA : 50% (8 calls matureds) · 📊 on Health : 38.9% · -0.9% (144 calls)
+13.2%
stock +13% · XLV +1%
matured Mar 19, 25
Canaccord Genuity ↗
Nov 11, 22
▲ Buy · 🎯$43
Price at call : $26.84 — upside +60%
Today : $20.86 — upside +106%
Expected +60% · Actual -21% · Reason (≥ +15%) : ✗ No
🎯 on PRVA : 50% (8 calls matureds) · 📊 on Health : 38.9% · -0.9% (144 calls)
-20.7%
stock -21% · XLV -5%
matured Nov 11, 23
Canaccord Genuity ↗
Aug 25, 22
▲ Buy · 🎯$50
Price at call : $39.01 — upside +28%
Today : $20.86 — upside +140%
Expected +28% · Actual -35% · Reason (≥ +15%) : ✗ No
🎯 on PRVA : 50% (8 calls matureds) · 📊 on Health : 38.9% · -0.9% (144 calls)
-34.6%
stock -35% · XLV +5%
matured Aug 25, 23
Canaccord Genuity ↗
May 13, 22
▲ Buy · 🎯$29
Price at call : $22.78 — upside +27%
Today : $20.86 — upside +39%
Expected +27% · Actual +16% · Reason (≥ +15%) : ✓ Yes
🎯 on PRVA : 50% (8 calls matureds) · 📊 on Health : 38.9% · -0.9% (144 calls)
+15.6%
stock +16% · XLV +2%
matured May 13, 23
Canaccord Genuity ↗
Mar 24, 22
▲ Buy · 🎯$44
Price at call : $25.65 — upside +72%
Today : $20.86 — upside +111%
Expected +72% · Actual +8% · Reason (≥ +15%) : ✗ No
🎯 on PRVA : 50% (8 calls matureds) · 📊 on Health : 38.9% · -0.9% (144 calls)
+8.1%
stock +8% · XLV -6%
matured Mar 24, 23
Canaccord Genuity ↗
May 24, 21
▲ Buy · 🎯$47
Price at call : $32.32 — upside +45%
Today : $20.86 — upside +125%
Expected +45% · Actual -29% · Reason (≥ +15%) : ✗ No
🎯 on PRVA : 50% (8 calls matureds) · 📊 on Health : 38.9% · -0.9% (144 calls)
-28.7%
stock -29% · XLV +5%
matured May 24, 22
Frequently asked questions
Should I buy Privia Health Group, Inc. stock?
This isn't buy advice. For Privia Health Group, Inc., the analyst consensus is "Buy", with an average price target of $32.00 (+53% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 75% of the time (4 calls tracked on Privia Health Group, Inc.). We show the numbers — you decide.
Is it too late to buy Privia Health Group, Inc.? How high can it go?
The most bullish analyst target on Privia Health Group, Inc. is $34.00 (+63% above today's price); the average is $32.00. That's the upside they see. Check how reliable those analysts have actually been on Privia Health Group, Inc. on our site before trusting it.
Is Privia Health Group, Inc. still a good buy?
The most useful "opinion" isn't an opinion — it's a track record: 17 analysts have a real record on Privia Health Group, Inc., the best hitting 75% over 4 calls. Current consensus: "Buy". Make your call on data, not noise.
Should you invest in Privia Health Group, Inc.? The case for and against
The arguments for and against, one by one, from the numbers: why invest in PRVA (and why hesitate).
What has Privia Health Group, Inc.'s past performance been?
Historical returns and a "how much if I had invested" calculator: PRVA performance & returns.
BIIB 
VRTX 
UNH 
REGN 
EW 
SRPT 
VEEV 
BSX